Clinical Trials
3 trialsNCT03038477 2020-09-14
A Study of Durvalumab in Patients With BR PDA Following Neoadjuvant Therapy and Successful Surgical Resection
University of Colorado, Denver
Phase 2 Withdrawn
NCT02885727 2019-09-12
Panc-Durval+RT
University of Maryland, Baltimore
Phase 2 Withdrawn
NCT02868632 2019-04-05
Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer
NYU Langone Health
Phase 1 Withdrawn